EPIC SCIENCES

In News

Epic's First Pharma Deal - Health API Guy

Health API Guy - Feb 28, 2026

Ten years of tropospheric ozone from DSCOVR EPIC: science and applications - Frontiers

Frontiers - Aug 17, 2025

The ultra-cold temperatures needed for epic nuclear science - BBC

BBC - Jan 13, 2026

Epic Sciences Raises $24M in Series G Financing to Continue Funding Commercialization of DefineMBC - Business Wire

Business Wire - Apr 13, 2023

Epic Sciences Launches New Corporate Branding and Website - PR Newswire

PR Newswire - May 13, 2019

Epic Sciences Raises $24M in Series G - citybiz

citybiz - Apr 17, 2023

Epic Sciences gathers $52M for blood tests that match cancer patients to therapies - Fierce Biotech

Fierce Biotech - Sep 17, 2018

Epic Sciences gets $24m to boost commercialisation of DefineMBC tests - Medical Device Network

Medical Device Network - Apr 17, 2023

Epic Science - American Scientist

American Scientist - Feb 12, 2018

Peter Kuhn Appointed University Professor - USC Dornsife

USC Dornsife - Mar 01, 2024

Summary of the 10th DSCOVR EPIC and NISTAR Science Team Meeting - NASA Science (.gov)

NASA Science (.gov) - Feb 14, 2025

PSMA-Targeted Radioligand Therapy and Liquid Biopsy Characterizing PSMA Expression in Men with Metastatic Castration-Resistant Prostate Cancer - Andrew Armstrong - UroToday

UroToday - Apr 21, 2023

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment